Korn Ferry (KFY)
NYSE: KFY
· Real-Time Price · USD
72.52
-0.73 (-1.00%)
At close: Aug 15, 2025, 11:51 AM
Korn Ferry Revenue Breakdown
| Period Ending | Apr 30, 2025 | Apr 30, 2024 | Apr 30, 2023 | Apr 30, 2022 | Apr 30, 2021 | Apr 30, 2020 | Apr 30, 2019 |
|---|---|---|---|---|---|---|---|
| Consumer Goods Revenue | 349.2M | 382.18M | 386.41M | 372.72M | 239.46M | 285.93M | 297.68M |
| Consumer Goods Revenue Growth | -8.63% | -1.10% | +3.67% | +55.65% | -16.25% | -3.95% | n/a |
| Education Non Profit And General Revenue | 177.72M | 184.93M | 143.3M | 131.81M | 116.57M | 126.67M | 349.97M |
| Education Non Profit And General Revenue Growth | -3.89% | +29.05% | +8.72% | +13.07% | -7.97% | -63.81% | n/a |
| Financial Service Revenue | 516.74M | 491.76M | 494.3M | 475.33M | 331.98M | 334.43M | 561.03M |
| Financial Service Revenue Growth | +5.08% | -0.51% | +3.99% | +43.18% | -0.73% | -40.39% | n/a |
| Industrial Revenue | 814.62M | 813.92M | 805.24M | 688.9M | 490.86M | 556.19M | 323.09M |
| Industrial Revenue Growth | +0.09% | +1.08% | +16.89% | +40.35% | -11.75% | +72.15% | n/a |
| Life Sciences And Healthcare Revenue | 475.78M | 485.32M | 522.37M | 501.46M | 355.67M | 343.95M | 260.92M |
| Life Sciences And Healthcare Revenue Growth | -1.97% | -7.09% | +4.17% | +40.99% | +3.41% | +31.82% | n/a |
| Technology Service Revenue | 396.03M | 404.57M | 483.79M | 456.5M | 275.51M | 285.56M | n/a |
| Technology Service Revenue Growth | -2.11% | -16.37% | +5.98% | +65.69% | -3.52% | n/a | n/a |
Revenue by Geography
| Period Ending | Apr 30, 2025 | Apr 30, 2024 | Apr 30, 2023 | Apr 30, 2022 | Apr 30, 2021 | Apr 30, 2020 | Apr 30, 2019 | Apr 30, 2018 | Apr 30, 2017 | Apr 30, 2016 | Apr 30, 2015 | Apr 30, 2014 | Apr 30, 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Countries Revenue | 954.88M | 1.25B | 1.01B | 1.03B | 782.47M | 852.86M | 864.01M | 988.75M | 836.65M | 622.53M | 471.13M | 453.02M | 395.84M |
| Other Countries Revenue Growth | -23.91% | +24.06% | -1.87% | +31.73% | -8.25% | -1.29% | -12.62% | +18.18% | +34.40% | +32.14% | +4.00% | +14.44% | n/a |
| United States Revenue | 1.45B | 1.51B | 255.8M | 247.62M | 189.89M | 204.27M | 202.06M | 778.47M | 728.87M | 669.59M | 557.02M | n/a | n/a |
| United States Revenue Growth | -3.96% | +489.46% | +3.30% | +30.40% | -7.04% | +1.10% | -74.04% | +6.80% | +8.85% | +20.21% | n/a | n/a | n/a |
| United Kingdom Revenue | 327.04M | n/a | 1.57B | 1.35B | 837.68M | 875.61M | 859.97M | n/a | n/a | n/a | n/a | n/a | n/a |
| United Kingdom Revenue Growth | n/a | n/a | +16.30% | +60.97% | -4.33% | +1.82% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 | Apr 30, 2020 | Jan 31, 2020 | Oct 31, 2019 | Jul 31, 2019 | Apr 30, 2019 | Jan 31, 2019 | Oct 31, 2018 | Jul 31, 2018 | Apr 30, 2018 | Jan 31, 2018 | Oct 31, 2017 | Jul 31, 2017 | Apr 30, 2017 | Jan 31, 2017 | Oct 31, 2016 | Jul 31, 2016 | Apr 30, 2016 | Jan 31, 2016 | Oct 31, 2015 | Jul 31, 2015 | Apr 30, 2015 | Jan 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 68.62M | 65.33M | 64.54M | 60M | 64.72M | 62.66M | 519.6M | 545.8M | 557.56M | 552.17M | 529.85M | 530.08M | 529.84M | 506.68M | 64.06M | 50.27M | 431.29M | 373.6M | 46.48M | 331.1M | 343.31M | 419.95M | 62.01M | 65.81M | 396.01M | 61.18M | 57.74M | 490.63M | 62.01M | 369.27M | 58.6M | 58.26M | 59.94M | 56.82M | 54.13M | 55.34M | 360.42M | 57.4M | 44.56M | 37.49M | 224.52M | 201.57M |
| Selling, General, and Administrative Revenue Growth | +5.05% | +1.21% | +7.57% | -7.30% | +3.29% | -87.94% | -4.80% | -2.11% | +0.98% | +4.21% | -0.04% | +0.05% | +4.57% | +690.89% | +27.45% | -88.34% | +15.44% | +703.86% | -85.96% | -3.55% | -18.25% | +577.24% | -5.77% | -83.38% | +547.31% | +5.96% | -88.23% | +691.21% | -83.21% | +530.12% | +0.59% | -2.80% | +5.49% | +4.96% | -2.18% | -84.65% | +527.97% | +28.80% | +18.86% | -83.30% | +11.39% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |